Latham & Watkins Advises Goodgrower in Connection with Kindbody’s US$32 Million Series B Funding

A Boston-based team advised the company in the funding.

July 28, 2020

Kindbody, a fast growing health and technology company providing fertility, gynecology, and family-building care, has announced US$32 million in Series B funding, bringing its total amount raised to US$64 million. The Series B round was led by Perceptive Advisors, with participation from existing investors RRE, GV (formerly Google Ventures), and Freemark Capital. New investors include major private and public healthcare funds Rock Springs Capital, Goodgrower and Claritas Capital as well as NFP Ventures, the early stage investment arm of NFP, a leading insurance broker and consultant. 

Latham & Watkins represented Goodgrower in the transaction with a corporate team led by Boston/New York partner Kristen Grannis, with Boston associates Laki Triantafylidis and Jennifer Yoon. Advice was also provided on healthcare matters by Los Angeles Counsel Jennifer Yoo, with Houston associate Felicia Alexander.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.